3 results
Approved WMOCompleted
Primary objective* To evaluate the effect of macitentan 10 mg on pulmonary vascular resistance (PVR) at rest in comparison with placebo in subjects with inoperable chronic thromboembolic pulmonary hypertension (CTEPH).Secondary objectives* To…
Approved WMOWill not start
To demonstrate that macitentan improves exercise capacity in comparison with placebo in subjects with Eisenmenger Syndrome (ES).
Approved WMOPending
This study aims to investigate the effect of analgetics on a functional capacity evaluation (FCE) and self reported disability in patients with CLBP.